Search Legislation

Advanced Search

Regulation (EC) No 1223/2009 of the European Parliament and of the CouncilShow full title

Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)

Help about what version

What Version

Help about advanced features

Advanced Features

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes to legislation:

There are currently no known outstanding effects for the Regulation (EC) No 1223/2009 of the European Parliament and of the Council, Preamble. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

PreambleU.K.

Without prejudice to other provisions in this Regulation, a colorant shall include its salts and lakes and when a colorant is expressed as a specific salt, its other salts and lakes shall also be included.

a

For use as a UV-Filter, see Annex VI, No. 27.

b

[F1For use as a UV-filter, see Annex VI, No 30 and No 30a.]

Reference numberSubstance identificationConditionsWording of conditions of use and warnings
Chemical NameColour index Number/Name of Common Ingredients GlossaryCAS numberEC numberColourProduct type, Body partsMaximum concentration in ready for use preparationOther
abcdefghij
1Sodium tris(1,2-naphthoquinone 1-oximato-O,O')ferrate(1-)10006GreenRinse-off products
2Trisodium tris[5,6-dihydro-5-(hydroxyimino)-6-oxonaphthalene-2-sulphonato(2-)-N5,O6]ferrate(3-)10020GreenNot to be used in products applied on mucous membranes
3Disodium 5,7-dinitro-8-oxidonaphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments10316YellowNot to be used in eye products
42-[(4-Methyl-2-nitrophenyl)azo]-3-oxo-N-phenylbutyramide11680YellowNot to be used in products applied on mucous membranes
52-[(4-Chloro-2-nitrophenyl)azo]-N-(2-chlorophenyl)-3-oxobutyramide11710YellowNot to be used in products applied on mucous membranes
62-[(4-Methoxy-2-nitrophenyl)azo]-3-oxo-N-(o-tolyl)butyramide11725OrangeRinse-off products
74-(Phenylazo)resorcinol11920Orange
84-[(4-Ethoxyphenyl)azo]naphthol12010RedNot to be used in products applied on mucous membranes
91-[(2-Chloro-4-nitrophenyl)azo]-2-naphthol and its insoluble barium, strontium and zirconium lakes, salts and pigments12085Red3 %
101-[(4-Methyl-2-nitrophenyl)azo]-2-naphthol12120RedRinse-off products
113-Hydroxy-N-(o-tolyl)-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide12370RedRinse-off products
12N-(4-Chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide12420RedRinse-off products
134-[(2,5-Dichlorophenyl)azo]-N-(2,5-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide12480BrownRinse-off products
14N-(5-Chloro-2,4-dimethoxyphenyl)-4-[[5-[(diethylamino)sulphonyl]-2-methoxyphenyl]azo]-3-hydroxynaphthalene-2-carboxamide12490Red
152,4-Dihydro-5-methyl-2-phenyl-4-(phenylazo)-3H-pyrazol-3-one12700YellowRinse-off products
16Disodium 2-amino-5-[(4-sulphonatophenyl)azo]benzenesulphonate13015Yellow
17Sodium 4-(2,4-dihydroxyphenylazo)benzenesulphonate14270Orange
18Disodium 3-[(2,4-dimethyl-5-sulphonatophenyl)azo]-4-hydroxynaphthalene-1-sulphonate14700Red
19Disodium 4-hydroxy-3-[(4-sulphonatonaphthyl)azo]naphthalenesulphonate14720222-657-4RedPurity criteria as set out in Commission Directive 95/45/EC (E 122)
20Disodium 6-[(2,4-dimethyl-6-sulphonatophenyl)azo]-5-hydroxynaphthalene-1-sulphonate14815Red
21Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments15510OrangeNot to be used in eye products
22Calcium disodium bis[2-chloro-5-[(2-hydroxy-1-naphthyl)azo]-4-sulphonatobenzoate]15525Red
23Barium bis[4-[(2-hydroxy-1-naphthyl)azo]-2-methylbenzenesul-phonate]15580Red
24Sodium 4-[(2-Hydroxy-1-naphthyl)azo]naphthalenesulphonate15620RedRinse-off products
25Sodium 2-[(2-hydroxynaphthyl)azo]naphthalenesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments15630Red3 %
26Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate]15800RedNot to be used in products applied on mucous membranes
27Disodium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate and its insoluble barium, strontium and zirconium lakes, salts and pigments15850226-109-5RedPurity criteria as set out in Commission Directive 95/45/EC (E 180)
28Disodium 4-[(5-chloro-4-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate and its insoluble barium, strontium and zirconium lakes, salts and pigments15865Red
29Calcium 3-hydroxy-4-[(1-sulphonato-2-naphthyl)azo]-2-naphthoate15880Red
30Disodium 6-hydroxy-5-[(3-sulphonatophenyl)azo]naphthalene-2-sulphonate15980Orange
31Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments15985220-491-7YellowPurity criteria as set out in Commission Directive 95/45/EC (E 110)
32Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate16035247-368-0RedPurity criteria as set out in Commission Directive 95/45/EC (E 129)
33Trisodium 3-hydroxy-4-[(4'-sulphonatonaphthyl)azo]naphthalene-2,7-disulphonate16185213-022-2RedPurity criteria as set out in Commission Directive 95/45/EC (E 123)
34Disodium 7-hydroxy-8-(phenylazo)naphthalene-1,3-disulphonate16230OrangeNot to be used in products applied on mucous membranes
35Trisodium 1-(1-naphthylazo)-2-hydroxynaphthalene-4',6,8-trisulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments16255220-036-2RedPurity criteria as set out in Commission Directive 95/45/EC (E 124)
36Tetrasodium 7-hydroxy-8-[(4-sulphonato-1-naphthyl)azo]naphthalene-1,3,6-trisulphonate16290Red
37Disodium 5-amino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments17200Red
38Disodium 5-acetylamino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate18050223-098-9RedNot to be used in products applied on mucous membranesPurity criteria as set out in Commission Directive 95/45/EC (E 128)
392,7-Naphthalenedisulfonic acid, 3-((4-cyclohexyl-2-methylphenyl)azo)-4-hydroxy-5-(((4-methylphenyl)sulfonyl)amino)-, disodium salt18130RedRinse-off products
40Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)18690YellowRinse-off products
41Disodium hydrogen bis[5-chloro-3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxybenzenesulphonato(3-)]chromate(3-)18736RedRinse-off products
42Sodium 4-(3-hydroxy-5-methyl-4-(phenylazo)pyrazol-2-yl)benzenesulphonate18820YellowRinse-off products
43Disodium 2,5-dichloro-4-(5-hydroxy-3-methyl-4-((sulphophenyl)azo)pyrazol-1-yl)benzenesulphonate18965Yellow
44Trisodium 5-hydroxy-1-(4-sulphophenyl)-4-((4-sulphophenyl)azo)pyrazole-3-carboxylate and its insoluble barium, strontium and zirconium lakes, salts and pigments19140217-699-5YellowPurity criteria as set out in Commission Directive 95/45/EC (E 102)
45N,N'-(3,3'-Dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[2-[(2,4-dichlorophenyl)azo]-3-oxobutyramide]20040YellowRinse-off productsMaximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm
46Sodium 4-amino-5-hydroxy-3-((4-nitrophenyl)azo)-6-(phenylazo)naphthalene-2,7-disulphonate20470BlackRinse-off products
472,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxobutyramide]21100YellowRinse-off productsMaximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm
482,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide]21108YellowRinse-off productsMaximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm
492,2'-[Cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol]21230YellowNot to be used in products applied on mucous membranes
50Disodium 4,6-dihydroxy-3-[[4-[1-[4-[[1-hydroxy-7-[(phenylsulphonyl)oxy]-3-sulphonato-2-naphthyl]azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-2-sulphonate24790RedRinse-off products
511-(4-(Phenylazo)phenylazo)-2-naphthol26100RedNot to be used in products applied on mucous membranes

Purity criteria:

aniline ≤ 0,2 %

2-naphtol ≤ 0,2 %

4-aminoazobenzene ≤ 0,1 %

1-(phenylazo)-2-naphtol ≤ 3 %

1-[2-(phenylazo)phenylazo]-2-napthalenol ≤ 2 %

52Tetrasodium 6-amino-4-hydroxy-3-[[7-sulphonato-4-[(4-sulphonatophenyl)azo]-1-naphthyl]azo]naphthalene-2,7-disulphonate27755Black
53Tetrasodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate28440219-746-5BlackPurity criteria as set out in Commission Directive 95/45/EC (E 151)
54Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt, reaction products with 4-[(4-aminophenyl)azo] benzenesulfonic acid, sodium salts40215OrangeRinse-off products
55beta Carotene40800230-636-6OrangePurity criteria as set out in Commission Directive 95/45/EC (E160a)
568'-apo-.beta.-Caroten-8'-al40820OrangePurity criteria as set out in Commission Directive 95/45/EC (E 160e)
57Ethyl 8'-apo-.beta.-caroten-8'-oate40825214-173-7OrangePurity criteria as set out in Commission Directive 95/45/EC (E 160f)
58Canthaxanthin40850208-187-2OrangePurity criteria as set out in Commission Directive 95/45/EC (E 161g)
59Ammonium, (4-(alpha-(p-(diethylamino)phenyl)-2,4-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethyl-, hydroxide, monosodium salt42045BlueNot to be used in products applied on mucous membranes
60Ethanaminium, N-(4-((4-(diethylamino)phenyl)(5-hydroxy-2,4-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, hydroxide, inner salt, calcium salt (2:1) and its insoluble barium, strontium and zirconium lakes, salts and pigments42051222-573-8BluePurity criteria as set out in Commission Directive 95/45/EC (E 131)
61Benzene-methanaminium, N-ethyl-N-(4-((4-(ethyl((3-sulfophenyl)methyl)amino) phenyl)(4-hydroxy-2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt42053Green
62Hydrogen (benzyl)[4-[[4-[benzylethylamino]phenyl](2,4-disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)ammonium, sodium salt42080BlueRinse-off products
63Benzene-methanaminium, N-ethyl-N-(4-((4-(ethyl((3-sulfophenyl)methyl)amino) phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt42090223-339-8BluePurity criteria as set out in Commission Directive 95/45/EC (E 133)
64Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt42100GreenRinse-off products
65Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt42170GreenRinse-off products
66(4-(4-Aminophenyl)(4-iminocyclohexa-2,5-dienylidene)methyl)-2-methylaniline hydrochloride42510VioletNot to be used in products applied on mucous membranes
674-[(4-Amino-m-tolyl)(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]-o-toluidine monohydrochloride42520VioletRinse-off products5ppm
68Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt42735BlueNot to be used in products applied on mucous membranes
69[4-[[4-Anilino-1-naphthyl][4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride44045BlueNot to be used in products applied on mucous membranes
70Hydrogen [4-[4-(dimethylamino)-.alpha.-(2-hydroxy-3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, monosodium salt44090221-409-2GreenPurity criteria as set out in Commission Directive 95/45/EC (E 142)
71Hydrogen 3,6-bis(diethylamino)-9-(2,4-disulphonatophenyl)xanthylium, sodium salt45100RedRinse-off products
72Hydrogen 9-(2-carboxylatophenyl)-3-(2-methylanilino)-6-(2-methyl-4-sulphoanilino)xanthylium, monosodium salt45190VioletRinse-off products
73Hydrogen 9-(2,4-disulphonatophenyl)-3,6-bis(ethylamino)-2,7-dimethylxanthylium, monosodium salt45220RedRinse-off products
74Disodium 2-(3-oxo-6-oxidoxanthen-9-yl)benzoate45350Yellow6 %
754',5'-Dibromo-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one and its insoluble barium, strontium and zirconium lakes, salts and pigments45370OrangeNot more than 1 % 2-(6-hydroxy-3-oxo-3H-xanthen-9-y1) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
76Disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments45380RedNot more than 1 % 2-(6-hydroxy-3-oxo-3H-xanthen-9-y1) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
773',6'-Dihydroxy-4',5'-dinitrospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one45396Orange1 %, when used in lip productsOnly in free acid form, when used in lip products
78Dipotassium 3,6-dichloro-2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate45405RedNot to be used in eye productsNot more than 1 % 2-(6-hydroxy-3-oxo-3Η xanthen-9-yl) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
793,4,5,6-Tetrachloro-2-(1,4,5,8-tetrabromo-6-hydroxy-3-oxoxanthen-9-yl)benzoic acid and its insoluble barium, strontium and zirconium lakes, salts and pigments45410RedNot more than 1 % 2-(6-hydroxy-3-oxo-3Η xanthen-9-yl) benzoic acid and 2 % 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl) benzoic acid
80Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments45430240-474-8RedPurity criteria as set out in Commission Directive 95/45/EC (E 127)
811,3-Isobenzofurandione, reaction products with methylquinoline and quinoline47000YellowNot to be used in products applied on mucous membranes
821H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts47005305-897-5YellowPurity criteria as set out in Commission Directive 95/45/EC (E 104)
83Hydrogen 9-[(3-methoxyphenyl)amino]-7-phenyl-5-(phenylamino)-4,10-disulphonatobenzo[a]phenazinium, sodium salt50325VioletRinse-off products
84Sulfonated nigrosine color50420BlackNot to be used in products applied on mucous membranes
858,18-Dichloro-5,15-diethyl-5,15-dihydrodiindolo[3,2-b:3',2'-m]triphenodioxazine51319VioletRinse-off products
861,2-Dihydroxyanthraquinone58000Red
87Trisodium 8-hydroxypyrene-1,3,6-trisulphonate59040GreenNot to be used in products applied on mucous membranes
881-Anilino-4-hydroxyanthraquinone60724VioletRinse-off products
891-Hydroxy-4-(p-toluidino)anthraquinone60725Violet
90Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate60730VioletNot to be used in products applied on mucous membranes
911,4-bis(p-Tolylamino)anthraquinone61565Green
92Disodium 2,2'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-methylsulphonate)61570Green
93Sodium 3,3'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(2,4,6-trimethylbenzenesulphonate)61585BlueRinse-off products
94Sodium 1-amino-4-(cyclohexylamino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate62045BlueRinse-off products
956,15-Dihydroanthrazine-5,9,14,18-tetrone69800Blue
967,16-dichloro-6,15-dihydroanthrazine-5,9,14,18-tetrone69825Blue
97Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione71105OrangeNot to be used in products applied on mucous membranes
982-(1,3-Dihydro-3-oxo-2H-indazol-2-ylidene)-1,2-dihydro-3H-indol-3-one73000Blue
99Disodium 5,5'-(2-(1,3-dihydro-3-oxo-2H-indazol-2-ylidene)-1,2-dihydro-3H-indol-3-one)disulphonate73015212-728-8BluePurity criteria as set out in Commission Directive 95/45/EC (E 132)
1006-Chloro-2-(6-chloro-4-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methylbenzo[b]thiophene-3(2H)-one73360Red
1015-Chloro-2-(5-chloro-7-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-7-methylbenzo[b]thiophene-3(2H)-one73385Violet
1025,12-Dihydroquino[2,3-b]acridine-7,14-dione73900VioletRinse-off products
1035,12-Dihydro-2,9-dimethylquino[2,3-b]acridine-7,14-dione73915RedRinse-off products
10429H,31H-Phthalocyanine74100BlueRinse-off products
10529H,31H-Phthalocyaninato(2-)-N29,N30,N31,N32 copper74160Blue
106Disodium [29H,31H-phthalocyaninedisulphonato (4-)-N29,N30,N31,N32] cuprate (2-)74180BlueRinse-off products
107Polychloro copper phthalocyanine74260GreenNot to be used in eye products
1088,8'-diapo-.psi.,.psi.-Carotenedioic acid75100Yellow
109Annatto75120215-735-4/289-561-2/230-248-7OrangePurity criteria as set out in Commission Directive 95/45/EC (E 160b)
110Lycopene75125—YellowPurity criteria as set out in Commission Directive 95/45/EC (E 160d)
111CI Food Orange 575130214-171-6OrangePurity criteria as set out in Commission Directive 95/45/EC (E 160a)
112(3R)-beta-4-Caroten-3-ol75135Yellow
1132-Amino-1,7-dihydro-6H-purin-6-one75170White
114Curcumins75300207-280-5YellowPurity criteria as set out in Commission Directive 95/45/EC (E 100)
115Carmines75470215-680-6/215-023-3/215-724-4RedPurity criteria as set out in Commission Directive 95/45/EC (E 120)
116Trisodium (2S-trans)-[18-carboxy-20-(carboxymethyl)-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24]cuprate(3-) (Chlorophylls)75810215-800-7/207-536-6/208-272-4/287-483-3/239-830-5/246-020-5GreenPurity criteria as set out in Commission Directive 95/45/EC (E 140, E 141)
117Aluminium77000231-072-3WhitePurity criteria as set out in Commission Directive 95/45/EC (E 173)
118Aluminium hydroxide sulphate77002White
119Natural hydrated aluminium silicate, Al2O3.2SiO2.2H2O, containing calcium, magnesium or iron carbonates, ferric hydroxide, quartz-sand, mica, etc. as impurities77004White
120Lazurite77007Blue
121Aluminum silicate coloured with ferric oxide77015Red
122Barium sulfate77120White
123Bismuth chloride oxide77163White
124Calcium carbonate77220207-439-9/215-279-6WhitePurity criteria as set out in Commission Directive 95/45/EC (E 170)
125Calcium sulfate77231White
[F2126 Carbon black 77266 1333-86-4, 7440-44-0 215-609-9, 231-153-3, 931-328-0, 931-334-3 Black Purity > 97 %, with the following impurity profile: Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benzo(a)pyrene ≤ 5 ppb, dibenz(a,h)anthracene ≤ 5 ppb, total As ≤ 3 ppm, total Pb ≤ 10 ppm, total Hg ≤ 1 ppm.
126a Carbon black

77266 (nano)

Carbon Black (nano)

1333-86-4, 7440-44-0 215-609-9, 231-153-3, 931-328-0, 931-334-3 Black 10 %

Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.

Only nanomaterials having the following characteristics are allowed:

  • Purity > 97 %, with the following impurity profile: Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benzo(a)pyrene ≤ 5 ppb, dibenz(a,h)anthracene ≤ 5 ppb, total As ≤ 3 ppm, total Pb ≤ 10 ppm, and total Hg ≤ 1 ppm;

  • Primary particle size ≥ 20 nm.

]
127Charcoal, bone. A fine black powder obtained by burning animal bones in a closed container. It consists primarily of calcium phosphate and carbon77267Black
128Coke black77268:1Black
129Chromium (III) oxide77288Greenfree from chromate ion
130Chromium (III) hydroxide77289Greenfree from chromate ion
131Cobalt Aluminum Oxide77346Green
132Copper77400Brown
133Gold77480231-165-9BrownPurity criteria as set out in Commission Directive 95/45/EC (E 175)
134Iron oxide77489Orange
135Iron Oxide Red77491215-168-2RedPurity criteria as set out in Commission Directive 95/45/EC (E 172)
136Iron Oxide Yellow7749251274-00-1257-098-5YellowPurity criteria as set out in Commission Directive 95/45/EC (E 172)
137Iron Oxide Black77499235-442-5BlackPurity criteria as set out in Commission Directive 95/45/EC (E 172)
138Ferric Ammonium Ferrocyanide77510Bluefree from cyanide ions
139Magnesium carbonate77713White
140Ammonium manganese(3+) diphosphate77742Violet
141Trimanganese bis (orthophosphate)77745Red
142Silver77820231-131-3WhitePurity criteria as set out in Commission Directive 95/45/EC (E 174)
143Titanium dioxidea77891236-675-5WhitePurity criteria as set out in Commission Directive 95/45/EC (E 171)
[F3144 Zinc oxide b 77947 1314-13-2 215-222-5 White Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. ]
145RiboflavinLactoflavin201-507-1/204-988-6YellowPurity criteria as set out in Commission Directive 95/45/EC (E 101)
146CaramelCaramel232-435-9BrownPurity criteria as set out in Commission Directive 95/45/EC (E 150a-d)
147Paprika extract, Capsanthin, capsorubinCapsanthin, capsorubin207-364-1/207-425-2OrangePurity criteria as set out in Commission Directive 95/45/EC (E 160c)
148Beetroot redBeetroot Red7659-95-2231-628-5RedPurity criteria as set out in Commission Directive 95/45/EC (E 162)
149

Anthocyanins

(Cyanidin,

Peonidin

Malvidin

Delphinidin

Petunidin

Pelargonidin)

Anthocyanins

528-58-5

134-01-0

528-53-0

643-84-5

134-04-3

208-438-6

205-125-6

211-403-8

208-437-0

—

205-127-7

RedPurity criteria as set out in Commission Directive 95/45/EC (E 163)
150Aluminium, zinc, magnesium and calcium stearates

Aluminum stearate

Zinc stearate

Magnesium stearate

Calcium stearate

7047-84-9

557-05-1

557-04-0

216-472-8

230-325-5

209-151-9

209-150-3

216-472-8

White
151Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxideBromothymol blue76-59-5200-971-2BlueRinse-off products
152Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-3-methyl-,S,S-dioxideBromocresol green76-60-8200-972-8GreenRinse-off products
153Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonateAcid red 19512220-24-5—RedNot to be used in products applied on mucous membranes

Textual Amendments

Back to top

Options/Help

Print Options

You have chosen to open the Whole Regulation

The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources